• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

反环肽 RC-101 的前配方和在生物体液中的稳定性,一种有潜力的抗 HIV 局部用杀微生物剂。

Preformulation and stability in biological fluids of the retrocyclin RC-101, a potential anti-HIV topical microbicide.

机构信息

Magee-Womens Research Institute, 204 Craft Avenue, Pittsburgh, PA, 15213, USA.

出版信息

AIDS Res Ther. 2011 Jul 29;8:27. doi: 10.1186/1742-6405-8-27.

DOI:10.1186/1742-6405-8-27
PMID:21801426
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3199744/
Abstract

BACKGROUND

RC-101, a cationic peptide retrocyclin analog, has in vitro activity against HIV-1. Peptide drugs are commonly prone to conformational changes, oxidation and hydrolysis when exposed to excipients in a formulation or biological fluids in the body, this can affect product efficacy. We aimed to investigate RC-101 stability under several conditions including the presence of human vaginal fluids (HVF), enabling the efficient design of a safe and effective microbicide product. Stability studies (temperature, pH, and oxidation) were performed by HPLC, Circular Dichroism, and Mass Spectrometry (LC-MS/MS). Additionally, the effect of HVF on formulated RC-101 was evaluated with fluids collected from healthy volunteers, or from subjects with bacterial vaginosis (BV). RC-101 was monitored by LC-MS/MS for up to 72 h.

RESULTS

RC-101 was stable at pH 3, 4, and 7, at 25 and 37°C. High concentrations of hydrogen peroxide resulted in less than 10% RC-101 reduction over 24 h. RC-101 was detected 48 h after incubation with normal HVF; however, not following incubation with HVF from BV subjects.

CONCLUSIONS

Our results emphasize the importance of preformulation evaluations and highlight the impact of HVF on microbicide product stability and efficacy. RC-101 was stable in normal HVF for at least 48 h, indicating that it is a promising candidate for microbicide product development. However, RC-101 stability appears compromised in individuals with BV, requiring more advanced formulation strategies for stabilization in this environment.

摘要

背景

RC-101 是一种阳离子肽类 retrocyclin 类似物,对 HIV-1 具有体外活性。肽类药物在制剂中暴露于赋形剂或体内生物体液时,通常容易发生构象变化、氧化和水解,这会影响产品的疗效。我们旨在研究 RC-101 在几种条件下的稳定性,包括存在人阴道液(HVF),从而能够有效地设计安全有效的杀微生物产品。通过 HPLC、圆二色性和质谱(LC-MS/MS)进行稳定性研究(温度、pH 值和氧化)。此外,还评估了 HVF 对配方 RC-101 的影响,使用来自健康志愿者或细菌性阴道病(BV)受试者的流体进行评估。通过 LC-MS/MS 监测 RC-101 长达 72 小时。

结果

RC-101 在 pH 值为 3、4 和 7、25°C 和 37°C 时稳定。高浓度的过氧化氢在 24 小时内导致 RC-101 减少不到 10%。RC-101 在与正常 HVF 孵育 48 小时后被检测到;然而,在与 BV 受试者的 HVF 孵育后未被检测到。

结论

我们的研究结果强调了预配方评估的重要性,并强调了 HVF 对杀微生物产品稳定性和疗效的影响。RC-101 在正常 HVF 中至少稳定 48 小时,表明它是杀微生物产品开发的有前途的候选物。然而,RC-101 在 BV 个体中的稳定性似乎受到损害,需要更先进的配方策略来稳定这种环境。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b64f/3199744/fa16173dbe7a/1742-6405-8-27-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b64f/3199744/2019c1274250/1742-6405-8-27-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b64f/3199744/a18e02f5d3bf/1742-6405-8-27-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b64f/3199744/7fe96f2c1642/1742-6405-8-27-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b64f/3199744/fa16173dbe7a/1742-6405-8-27-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b64f/3199744/2019c1274250/1742-6405-8-27-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b64f/3199744/a18e02f5d3bf/1742-6405-8-27-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b64f/3199744/7fe96f2c1642/1742-6405-8-27-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b64f/3199744/fa16173dbe7a/1742-6405-8-27-4.jpg

相似文献

1
Preformulation and stability in biological fluids of the retrocyclin RC-101, a potential anti-HIV topical microbicide.反环肽 RC-101 的前配方和在生物体液中的稳定性,一种有潜力的抗 HIV 局部用杀微生物剂。
AIDS Res Ther. 2011 Jul 29;8:27. doi: 10.1186/1742-6405-8-27.
2
Formulation development of retrocyclin 1 analog RC-101 as an anti-HIV vaginal microbicide product.反回旋酶 1 类似物 RC-101 作为抗 HIV 阴道杀微生物剂产品的配方开发。
Antimicrob Agents Chemother. 2011 May;55(5):2282-9. doi: 10.1128/AAC.01190-10. Epub 2011 Feb 14.
3
A Cationic Amphipathic Tilapia Piscidin 4 Peptide-Based Antimicrobial Formulation Promotes Eradication of Bacterial Vaginosis-Associated Bacterial Biofilms.一种基于阳离子两亲性罗非鱼杀鱼菌素4肽的抗菌制剂可促进细菌性阴道病相关细菌生物膜的清除。
Front Microbiol. 2022 Mar 23;13:806654. doi: 10.3389/fmicb.2022.806654. eCollection 2022.
4
The formulated microbicide RC-101 was safe and antivirally active following intravaginal application in pigtailed macaques.经阴道应用于恒河猴后,配方型杀微生物剂 RC-101 具有安全性和抗病毒活性。
PLoS One. 2010 Nov 29;5(11):e15111. doi: 10.1371/journal.pone.0015111.
5
Antiviral activity of retrocyclin RC-101, a candidate microbicide against cell-associated HIV-1.逆转环素RC-101(一种抗细胞相关HIV-1的候选杀微生物剂)的抗病毒活性
AIDS Res Hum Retroviruses. 2013 Feb;29(2):391-6. doi: 10.1089/AID.2012.0135. Epub 2012 Oct 10.
6
Preformulation and Vaginal Film Formulation Development of Microbicide Drug Candidate CSIC for HIV prevention.用于预防HIV的候选杀微生物剂药物CSIC的处方前研究及阴道膜剂处方开发
J Pharm Innov. 2017 Jun;12(2):142-154. doi: 10.1007/s12247-017-9274-0. Epub 2017 Mar 3.
7
Retrocyclin inhibits Gardnerella vaginalis biofilm formation and toxin activity.反环孢菌素抑制阴道加德纳菌生物膜的形成和毒素活性。
J Antimicrob Chemother. 2012 Dec;67(12):2870-2. doi: 10.1093/jac/dks305. Epub 2012 Jul 31.
8
Retrocyclin RC-101 blocks HIV-1 transmission across cervical mucosa in an organ culture.逆转环素RC-101在器官培养中可阻断HIV-1通过宫颈黏膜的传播。
J Acquir Immune Defic Syndr. 2012 Aug 15;60(5):455-61. doi: 10.1097/QAI.0b013e318258b420.
9
The retrocyclin analogue RC-101 prevents human immunodeficiency virus type 1 infection of a model human cervicovaginal tissue construct.反向环素类似物RC-101可预防1型人类免疫缺陷病毒对人宫颈阴道组织模型构建体的感染。
Immunology. 2007 May;121(1):140-5. doi: 10.1111/j.1365-2567.2006.02553.x. Epub 2007 Jan 23.
10
Evaluation of the fusion inhibitor P3 peptide as a potential microbicide to prevent HIV transmission in women.评估融合抑制剂 P3 肽作为一种预防女性 HIV 传播的潜在杀微生物剂。
PLoS One. 2018 Apr 18;13(4):e0195744. doi: 10.1371/journal.pone.0195744. eCollection 2018.

引用本文的文献

1
Defensins: defenders of human reproductive health.防御素:守护人类生殖健康的卫士。
Hum Reprod Update. 2023 Jan 5;29(1):126-154. doi: 10.1093/humupd/dmac032.
2
A Cationic Amphipathic Tilapia Piscidin 4 Peptide-Based Antimicrobial Formulation Promotes Eradication of Bacterial Vaginosis-Associated Bacterial Biofilms.一种基于阳离子两亲性罗非鱼杀鱼菌素4肽的抗菌制剂可促进细菌性阴道病相关细菌生物膜的清除。
Front Microbiol. 2022 Mar 23;13:806654. doi: 10.3389/fmicb.2022.806654. eCollection 2022.
3
Mechanism through Which Retrocyclin Targets Flavivirus Multiplication.

本文引用的文献

1
Formulation development of retrocyclin 1 analog RC-101 as an anti-HIV vaginal microbicide product.反回旋酶 1 类似物 RC-101 作为抗 HIV 阴道杀微生物剂产品的配方开发。
Antimicrob Agents Chemother. 2011 May;55(5):2282-9. doi: 10.1128/AAC.01190-10. Epub 2011 Feb 14.
2
Effects of physiological fluids on physical-chemical characteristics and activity of topical vaginal microbicide products.
J Pharm Sci. 2008 Aug;97(8):3123-39. doi: 10.1002/jps.21192.
3
Griffithsin, a potent HIV entry inhibitor, is an excellent candidate for anti-HIV microbicide.格里菲斯菌素是一种有效的HIV进入抑制剂,是抗HIV杀微生物剂的极佳候选物。
Retrocyclin 靶向黄病毒复制的作用机制。
J Virol. 2021 Jul 12;95(15):e0056021. doi: 10.1128/JVI.00560-21.
4
Evaluation of the fusion inhibitor P3 peptide as a potential microbicide to prevent HIV transmission in women.评估融合抑制剂 P3 肽作为一种预防女性 HIV 传播的潜在杀微生物剂。
PLoS One. 2018 Apr 18;13(4):e0195744. doi: 10.1371/journal.pone.0195744. eCollection 2018.
5
Topical delivery of low-cost protein drug candidates made in chloroplasts for biofilm disruption and uptake by oral epithelial cells.叶绿体合成的低成本蛋白质候选药物的局部递送,用于生物膜破坏和口腔上皮细胞摄取。
Biomaterials. 2016 Oct;105:156-166. doi: 10.1016/j.biomaterials.2016.07.042. Epub 2016 Aug 2.
6
The Role of Cationic Polypeptides in Modulating HIV-1 Infection of the Cervicovaginal Mucosa.阳离子多肽在调节 HIV-1 感染宫颈阴道黏膜中的作用。
Antibiotics (Basel). 2014 Nov 26;3(4):677-93. doi: 10.3390/antibiotics3040677.
7
Can one size fit all? Approach to bacterial vaginosis in sub-Saharan Africa.一种方法能适用于所有人吗?撒哈拉以南非洲地区细菌性阴道病的治疗方法。
Ann Clin Microbiol Antimicrob. 2016 Mar 11;15:16. doi: 10.1186/s12941-016-0132-6.
8
Retrocyclins neutralize bacterial toxins by potentiating their unfolding.反转录环蛋白通过增强细菌毒素的解折叠作用来中和它们。
Biochem J. 2015 Apr 15;467(2):311-20. doi: 10.1042/BJ20150049.
9
Evaluation of degradation kinetics and physicochemical stability of tenofovir.替诺福韦的降解动力学及物理化学稳定性评估
Drug Test Anal. 2015 Mar;7(3):207-13. doi: 10.1002/dta.1656. Epub 2014 May 12.
10
Retrocyclin inhibits Gardnerella vaginalis biofilm formation and toxin activity.反环孢菌素抑制阴道加德纳菌生物膜的形成和毒素活性。
J Antimicrob Chemother. 2012 Dec;67(12):2870-2. doi: 10.1093/jac/dks305. Epub 2012 Jul 31.
J Med Primatol. 2007 Aug;36(4-5):244-53. doi: 10.1111/j.1600-0684.2007.00242.x.
4
The retrocyclin analogue RC-101 prevents human immunodeficiency virus type 1 infection of a model human cervicovaginal tissue construct.反向环素类似物RC-101可预防1型人类免疫缺陷病毒对人宫颈阴道组织模型构建体的感染。
Immunology. 2007 May;121(1):140-5. doi: 10.1111/j.1365-2567.2006.02553.x. Epub 2007 Jan 23.
5
Prevalence of bacterial vaginosis: 2001-2004 National Health and Nutrition Examination Survey data.细菌性阴道病的患病率:2001 - 2004年国家健康和营养检查调查数据。
Obstet Gynecol. 2007 Jan;109(1):114-20. doi: 10.1097/01.AOG.0000247627.84791.91.
6
A rapid, three-step process for the preformulation of a recombinant ricin toxin A-chain vaccine.一种用于重组蓖麻毒素A链疫苗处方前研究的快速三步法。
J Pharm Sci. 2007 Jan;96(1):44-60. doi: 10.1002/jps.20675.
7
Microbicides and other topical strategies to prevent vaginal transmission of HIV.预防HIV阴道传播的杀微生物剂及其他局部用药策略。
Nat Rev Immunol. 2006 May;6(5):371-82. doi: 10.1038/nri1848.
8
Preclinical evaluation of synthetic -2 RANTES as a candidate vaginal microbicide to target CCR5.合成型-2趋化因子调节正常T细胞表达和分泌因子(RANTES)作为靶向C-C趋化因子受体5(CCR5)的阴道杀微生物剂候选物的临床前评估
Antimicrob Agents Chemother. 2006 Apr;50(4):1497-509. doi: 10.1128/AAC.50.4.1497-1509.2006.
9
A novel bacterial mucinase, glycosulfatase, is associated with bacterial vaginosis.一种新型细菌粘蛋白酶——糖硫酸酯酶,与细菌性阴道病有关。
J Clin Microbiol. 2005 Nov;43(11):5504-8. doi: 10.1128/JCM.43.11.5504-5508.2005.
10
RC-101, a retrocyclin-1 analogue with enhanced activity against primary HIV type 1 isolates.RC-101,一种对1型原发性艾滋病毒分离株具有增强活性的逆转环素-1类似物。
AIDS Res Hum Retroviruses. 2004 Nov;20(11):1157-65. doi: 10.1089/aid.2004.20.1157.